Literature DB >> 15371944

Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification.

Jesse K McKenney1, Mahul B Amin, John R Srigley, Rafael E Jimenez, Jae Y Ro, David J Grignon, Robert H Young.   

Abstract

Basaloid proliferations of the prostate with morphologic patterns other than usual basal cell hyperplasia are rare, and the distinction between benign and malignant lesions has been difficult. We describe 23 such lesions and classify them into two groups: adenoid cystic-like hyperplasia and adenoid cystic or basaloid carcinoma. Adenoid cystic-like hyperplasia (n = 19) was characterized by an older age at presentation (mean, 71.8 years), transition zone location with background of nodular hyperplasia, multifocality, lobulation, circumscription, and small acini with occasional hyalinization. A cribriform pattern limited to small- and medium-sized glands, squamous metaplasia, and hypercellular myxoid stroma were occasionally seen. Adenoid cystic carcinoma (n = 3) was characterized by a younger age at presentation (mean, 46.0 years), peripheral zone involvement, and large acini that were often dilated and exhibited extensive interanastomoses, prominent intraglandular hyalinization, perineural invasion, and extraprostatic extension. Basaloid carcinoma (n = 1) showed infiltration between normal glands, perineural invasion, and extraprostatic extension but lacked a cribriform architecture. The degree of cytologic atypia and mitotic rate overlapped between the hyperplasia and carcinoma cases. Both hyperplastic lesions and adenoid cystic carcinomas showed a basal cell phenotype with strong immunoreactivity to cytokeratins 14 and 34betaE12, but the basaloid carcinoma was negative for these markers. In all cases, the proliferating basal cells were nonreactive for myoepithelial and prostatic secretory cell markers. The 8 patients with adenoid cystic-like hyperplasia with available follow-up information had no progression of disease (mean follow-up period, 8.6 years). One patient with adenoid cystic carcinoma died with widespread metastases, but the 3 other patients with carcinomas had no disease progression (mean follow-up period, 7.0 years). In conclusion, most florid basaloid proliferations of the prostate fall into one of two categories. In the first, there is a clear association with nodular hyperplasia (adenoid cystic-like hyperplasia) and, although cytologic atypia and mitoses may be seen, they are present within a lesion that retains an orderly, vaguely nodular (noninfiltrative) pattern. The second group of cases (adenoid cystic and basaloid carcinoma) shows a widespread, haphazard infiltrative growth pattern. This study suggests that adenoid cystic carcinomas are biologically indolent following prostatectomy but have a low risk of distant metastasis.

Entities:  

Mesh:

Year:  2004        PMID: 15371944     DOI: 10.1097/01.pas.0000138180.95581.e1

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

1.  Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE).

Authors:  Eric W Deutsch; Catherine A Ball; Jules J Berman; G Steven Bova; Alvis Brazma; Roger E Bumgarner; David Campbell; Helen C Causton; Jeffrey H Christiansen; Fabrice Daian; Delphine Dauga; Duncan R Davidson; Gregory Gimenez; Young Ah Goo; Sean Grimmond; Thorsten Henrich; Bernhard G Herrmann; Michael H Johnson; Martin Korb; Jason C Mills; Asa J Oudes; Helen E Parkinson; Laura E Pascal; Nicolas Pollet; John Quackenbush; Mirana Ramialison; Martin Ringwald; David Salgado; Susanna-Assunta Sansone; Gavin Sherlock; Christian J Stoeckert; Jason Swedlow; Ronald C Taylor; Laura Walashek; Anthony Warford; David G Wilkinson; Yi Zhou; Leonard I Zon; Alvin Y Liu; Lawrence D True
Journal:  Nat Biotechnol       Date:  2008-03       Impact factor: 54.908

Review 2.  The pathology of unusual subtypes of prostate cancer.

Authors:  Jing Li; Zhe Wang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

3.  Adenoid cystic/basal cell carcinoma of the prostate strongly expresses HER-2/neu.

Authors:  K A Iczkowski; R Montironi
Journal:  J Clin Pathol       Date:  2006-12       Impact factor: 3.411

4.  Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinoma.

Authors:  Kazumasa Komura; Teruo Inamoto; Motomu Tsuji; Naokazu Ibuki; Kohei Koyama; Takanobu Ubai; Haruhito Azuma; Yoji Katsuoka
Journal:  Int J Clin Oncol       Date:  2010-04-27       Impact factor: 3.402

5.  Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression.

Authors:  R Montironi; R Mazzucchelli; D Stramazzotti; M Scarpelli; A López Beltran; D G Bostwick
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

6.  Basaloid adenocarcinoma. A new variant of pulmonary adenocarcinoma.

Authors:  Valerio Marci; Marco Volante; Susanna Cappia; Luisella Righi; Corrado Novello; Giorgio V Scagliotti; Elisabeth Brambilla; Mauro Papotti
Journal:  Virchows Arch       Date:  2007-07-06       Impact factor: 4.064

7.  A Review Leveraging a Rare and Unusual Case of Basal Cell Carcinoma of the Prostate.

Authors:  Lin He; Christopher Metter; Vitaly Margulis; Payal Kapur
Journal:  Case Rep Pathol       Date:  2021-05-04

8.  Basaloid carcinoma of the prostate: A literature review with case report.

Authors:  Jeffrey Tuan; Hardev Pandha; Cathy Corbishley; Vincent Khoo
Journal:  Indian J Urol       Date:  2012-07

Review 9.  Basal cell carcinoma of the prostate: clinicopathologic analysis of three cases and a review of the literature.

Authors:  Kun Chang; Bo Dai; YunYi Kong; YuanYuan Qu; JianNong Wu; DingWei Ye; XuDong Yao; ShiLin Zhang; HaiLiang Zhang; Yao Zhu; WeiQiang Yao
Journal:  World J Surg Oncol       Date:  2013-08-13       Impact factor: 2.754

10.  Basal cell carcinoma of the prostate diagnosed incidentally with holmium laser enucleation of the prostate: How can we detect prior to benign prostatic hyperplasia surgery?

Authors:  Eiichiro Ohara; Hiroshi Aoki; Yosuke Arakawa; Atsushi Kato; Rie Shibuya; Shigeto Ishidoya
Journal:  IJU Case Rep       Date:  2021-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.